|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.20 EUR | -1.36% |
|
+2.39% | -13.24% |
| Jun. 03 | PharmaNutra Launches New Supplement Apportal Boost on the Market | AN |
| May. 14 | Futures slightly up but buying slows | AN |
| Capitalization | 460M 537M 428M 396M 735M 46.05B 818M 5.12B 1.96B 21.52B 2.01B 1.97B 78.65B | P/E ratio 2025 * |
21.8x | P/E ratio 2026 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise value | 442M 517M 412M 381M 707M 44.3B 787M 4.92B 1.88B 20.7B 1.94B 1.9B 75.65B | EV / Sales 2025 * |
3.33x | EV / Sales 2026 * | 2.9x |
| Free-Float |
34.25% | Yield 2025 * |
2.01% | Yield 2026 * | 2.43% |
More valuation ratios
* Estimated data
More news
More press releases
More news
| 1 week | +3.80% | ||
| Current month | +1.38% | ||
| 1 month | -4.87% | ||
| 3 months | -2.25% | ||
| 6 months | -7.98% | ||
| Current year | -12.04% |
| 1 week | 45.95 |  | 47.85 |
| 1 month | 45.2 | | 50.8 |
| Current year | 45.2 | | 60 |
| 1 year | 45.05 | | 61.2 |
| 3 years | 43.55 | | 72.4 |
| 5 years | 22 | | 80 |
| 10 years | 12 | | 80 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Lacorte
CEO | Chief Executive Officer | - | 2002-12-31 |
| Chief Tech/Sci/R&D Officer | - | - | |
Carlo Volpi
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Andrea Lacorte
CHM | Chairman | - | 2002-12-31 |
Carlo Volpi
BRD | Director/Board Member | - | 2008-12-31 |
| Director/Board Member | - | 2010-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.73% | +3.80% | -0.62% | -27.28% | 537M | ||
| +0.47% | +1.46% | -15.21% | +139.25% | 710B | ||
| +0.90% | +1.37% | +7.24% | -11.55% | 379B | ||
| +2.30% | +2.23% | +16.04% | +27.58% | 344B | ||
| -0.89% | +3.16% | -53.72% | +11.41% | 317B | ||
| -1.14% | +1.11% | +7.52% | -18.30% | 265B | ||
| -1.05% | +0.79% | +2.18% | +19.88% | 244B | ||
| -0.42% | +2.27% | -11.03% | -3.78% | 223B | ||
| +0.37% | +1.98% | -33.34% | -9.44% | 211B | ||
| +1.30% | +0.71% | -6.62% | +20.88% | 162B | ||
| Average | -0.04% | +1.62% | -8.76% | +14.86% | 285.51B | |
| Weighted average by Cap. | +0.02% | +1.10% | -9.66% | +37.86% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 133M 155M 124M 114M 212M 13.3B 236M 1.48B 565M 6.21B 582M 570M 22.71B | 149M 174M 139M 128M 238M 14.91B 265M 1.66B 633M 6.97B 652M 639M 25.46B |
| Net income | 21.3M 24.89M 19.85M 18.35M 34.07M 2.13B 37.93M 237M 90.63M 997M 93.36M 91.44M 3.65B | 24.15M 28.23M 22.5M 20.81M 38.63M 2.42B 43M 269M 103M 1.13B 106M 104M 4.13B |
| Net Debt | -17.5M -20.45M -16.31M -15.08M -27.99M -1.75B -31.16M -195M -74.46M -819M -76.7M -75.13M -3B | -28.7M -33.54M -26.74M -24.73M -45.91M -2.88B -51.11M -320M -122M -1.34B -126M -123M -4.91B |
More financial data
* Estimated data
Employees
118
Sector
Pharmaceuticals
Calendar
Sep. 07
- Q2 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-11 | 47.20 € | -1.36% | 2,208 |
| 25-07-10 | 47.85 € | +1.70% | 5,555 |
| 25-07-09 | 47.05 € | -0.63% | 2,848 |
| 25-07-08 | 47.35 € | +0.74% | 4,254 |
| 25-07-07 | 47.00 € | +0.86% | 8,014 |
Real-time Borsa Italiana, July 11, 2025 at 03:15 am EDT
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
47.85EUR
Average target price
82.00EUR
Spread / Average Target
+71.37%
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHN Stock
Select your edition
All financial news and data tailored to specific country editions
